Drug Discovery

Transfac subscriptions renewed by Merck & Co. and Schering-Plough Research Institute

Published in Gene Therapy Weekly, May 9th, 2002

Cognia Corp., developers and distributors of databases and knowledge tools for drug discovery, announced that Merck & Co., Inc., and Schering-Plough Research Institute have renewed their subscriptions to the Transfac Professional Suite, a database suite on transcription factors and gene regulation.

Merck & Co., Inc., and Schering-Plough Research Institute will continue to utilize the Transfac Professional Suite's in-depth gene regulation information.

In addition to the vast transcription factor data, the suite now includes composite regulatory element information, and mutant factor and binding site data, creating a robust gene regulation...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-05-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry